top of page
Search

June 2022 // News

  • andreachicca797
  • Jun 9, 2022
  • 1 min read

Updated: 6 days ago


Read about our success story in an article published by NCCR Transcure


In a last newsletter edition from NCCR Transcure, we can look behind the scenes of our technology transfer success story. Prof. Jürg Gertsch together with our CEO Andrea Chicca, illustrate the path that led to the conception and launch of Synendos Therapeutics, a spin-off of NCCR TransCure and University of Bern. Read the full article here:






Recent Posts

See All
September 2025 // News

Dr. Andrea Chicca, CEO, shares the highly promising results from Synendos Phase 1 Trials

 
 
October 2024 // News

Synendos Secures Innosuisse Funding to Advance Clinical Development of SYT-510

 
 
July 2024 // News

Synendos is excited to announce the publication of the latest article written by Andrea Chicca and Jürg Gertsch

 
 
bottom of page